Characterization of natural killer and natural killer–like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: Implications for adoptive cellular immunotherapy-Reference-Cited by-同舟云学术

Characterization of natural killer and natural killer–like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: Implications for adoptive cellular immunotherapy

Published:2009-10 Issue:10 Volume:37 Page:1216-1229
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Ayello Janet,van de Ven Carmella,Cairo Evan,Hochberg Jessica,Baxi Laxmi,Satwani Prakash,Cairo Mitchell S.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference50 articles.

1. Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors;Cairo;Biol Blood Marrow Transplant,2008

2. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation;Cairo;Blood,1997

3. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors;Laughlin;N Engl J Med,2001

4. Cord blood immunology and stem cell transplantation;Bradley;Human Immunol,2005

5. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration;van de Ven;Exp Hematol,2007

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of enhanced CD96 expression on NK cells by TGF-β1 in AML;International Immunopharmacology;2024-11

2. Natural Killer T-like Cells: Immunobiology and Role in Disease;International Journal of Molecular Sciences;2023-02-01

3. The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL);Current Treatment Options in Oncology;2022-03

4. Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56Dim NK cells;Innate Immunity;2019-05-08

5. Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors;Frontiers in Oncology;2019-02-11